Skip to main content
. 2018 Dec 1;11(12):5547–5560.

Figure 4.

Figure 4

Survival comparison of DLBCL patients with low and high XPO1 expression levels. A: overall survival (OS) of 131 DLBCL patients; B: progression-free survival (PFS) of 131 DLBCL patients; C: OS of 78 DLBCL patients with chemotherapy; D: PFS of 78 DLBCL patients undergoing chemotherapy. Annotation: DLBCL, diffuse large B-cell lymphoma; XPO1, exportin-1.